It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALC’s FA Score shows that 0 FA rating(s) are green whileCZMWY’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALC’s TA Score shows that 4 TA indicator(s) are bullish while CZMWY’s TA Score has 4 bullish TA indicator(s).
ALC (@Pharmaceuticals: Other) experienced а -2.41% price change this week, while CZMWY (@Pharmaceuticals: Other) price change was -6.32% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.70%. For the same industry, the average monthly price growth was -2.56%, and the average quarterly price growth was +2.10%.
ALC is expected to report earnings on Aug 20, 2025.
CZMWY is expected to report earnings on Dec 11, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
ALC | CZMWY | ALC / CZMWY | |
Capitalization | 42.4B | 4.42B | 959% |
EBITDA | 1.53B | 389M | 394% |
Gain YTD | 1.013 | 6.533 | 16% |
P/E Ratio | 38.11 | 24.29 | 157% |
Revenue | 9.93B | 2.17B | 458% |
Total Cash | 1.41B | 51.5M | 2,742% |
Total Debt | 5.2B | 147M | 3,539% |
ALC | CZMWY | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 67 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 79 Overvalued | 29 Undervalued | |
PROFIT vs RISK RATING 1..100 | 46 | 100 | |
SMR RATING 1..100 | 84 | 78 | |
PRICE GROWTH RATING 1..100 | 75 | 87 | |
P/E GROWTH RATING 1..100 | 69 | 68 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CZMWY's Valuation (29) in the null industry is somewhat better than the same rating for ALC (79) in the Hospital Or Nursing Management industry. This means that CZMWY’s stock grew somewhat faster than ALC’s over the last 12 months.
ALC's Profit vs Risk Rating (46) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CZMWY (100) in the null industry. This means that ALC’s stock grew somewhat faster than CZMWY’s over the last 12 months.
CZMWY's SMR Rating (78) in the null industry is in the same range as ALC (84) in the Hospital Or Nursing Management industry. This means that CZMWY’s stock grew similarly to ALC’s over the last 12 months.
ALC's Price Growth Rating (75) in the Hospital Or Nursing Management industry is in the same range as CZMWY (87) in the null industry. This means that ALC’s stock grew similarly to CZMWY’s over the last 12 months.
CZMWY's P/E Growth Rating (68) in the null industry is in the same range as ALC (69) in the Hospital Or Nursing Management industry. This means that CZMWY’s stock grew similarly to ALC’s over the last 12 months.
ALC | CZMWY | |
---|---|---|
RSI ODDS (%) | 2 days ago55% | 2 days ago53% |
Stochastic ODDS (%) | 2 days ago71% | 2 days ago64% |
Momentum ODDS (%) | 2 days ago44% | N/A |
MACD ODDS (%) | 2 days ago46% | 2 days ago71% |
TrendWeek ODDS (%) | 2 days ago49% | 2 days ago75% |
TrendMonth ODDS (%) | 2 days ago45% | 2 days ago70% |
Advances ODDS (%) | 2 days ago59% | 17 days ago60% |
Declines ODDS (%) | 4 days ago57% | 2 days ago77% |
BollingerBands ODDS (%) | 2 days ago58% | 2 days ago67% |
Aroon ODDS (%) | 2 days ago47% | 2 days ago78% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PSCH | 38.01 | 0.31 | +0.82% |
Invesco S&P SmallCap Health Care ETF | |||
DISV | 34.10 | 0.17 | +0.49% |
Dimensional International Sm Cp Val ETF | |||
HYBL | 28.46 | N/A | N/A |
SPDR® Blackstone High Income ETF | |||
ABXB | 19.64 | N/A | N/A |
Abacus Flexible Bond Leaders ETF | |||
NSI | 30.11 | -0.05 | -0.17% |
National Security Emerging Mkts Idx ETF |
A.I.dvisor indicates that over the last year, CZMWY has been loosely correlated with SMMNY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CZMWY jumps, then SMMNY could also see price increases.
Ticker / NAME | Correlation To CZMWY | 1D Price Change % | ||
---|---|---|---|---|
CZMWY | 100% | -0.22% | ||
SMMNY - CZMWY | 44% Loosely correlated | +0.82% | ||
SONVY - CZMWY | 38% Loosely correlated | +1.46% | ||
SAUHY - CZMWY | 37% Loosely correlated | -1.11% | ||
ALGN - CZMWY | 37% Loosely correlated | +2.18% | ||
ALC - CZMWY | 36% Loosely correlated | +0.35% | ||
More |